Sessa, C;
Balmaña, J;
Bober, SL;
Cardoso, MJ;
Colombo, N;
Curigliano, G;
Domchek, SM;
... ESMO, Guidelines Committee; + view all
(2023)
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.
Annals of Oncology
, 34
(1)
pp. 33-47.
10.1016/j.annonc.2022.10.004.
Preview |
Text
Ledermann_Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes_Pre-proof.pdf Download (1MB) | Preview |
Type: | Article |
---|---|
Title: | Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.annonc.2022.10.004 |
Publisher version: | https://doi.org/10.1016/j.annonc.2022.10.004 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
Keywords: | Risk-reduction, hereditary breast & ovarian cancer syndromes, BRCA, ESMO Clinical Practice Guideline |
UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute |
URI: | https://discovery.ucl.ac.uk/id/eprint/10158399 |
Archive Staff Only
View Item |